Brion W Murray

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|Oct 09, 2021
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations.

Brion W Murray, Evan Rogers, Dayong Zhai

|Jun 23, 2021
TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations.

Brion W Murray, Dayong Zhai, Wei Deng

|Oct 03, 2019
Countering Breast Cancer's Counterpunch.

Brion W Murray

Pageof 1

Frequent Collaborators

1 joint publications

Vivian Nguyen

1 joint publications

Han Zhang

1 joint publications

Siegfried H Reich

1 joint publications

Benjamin Solomon

1 joint publications

Alexander Drilon

1 joint publications

Yves A Millet

1 joint publications

Alexander I Spira

1 joint publications

Christina S Baik

1 joint publications

Min Hee Hong

1 joint publications

Elaine Shum

Frequent Collaborators

1 joint publications

Vivian Nguyen

1 joint publications

Han Zhang

1 joint publications

Siegfried H Reich

1 joint publications

Benjamin Solomon

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us